Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Marta Vaz Batista



Hospital Professor Doutor Fernando Fonseca EPE, Amadora

Marta Vaz Batista, MD, is a Medical Oncologist at Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal. Dr. Vaz Batista completed her Master´s Degree in Medicine at the Faculdade de Medicina da Universidade de Lisboa in 2014, and her residency in Medical Oncology in 2021. She has completed postgraduate studies in Nutrition in Oncology.

Her areas of interest are breast cancer, gynaecological cancer and palliative care.

Dr. Vaz-Batista is one of the authors and the medical monitor of DEBBRAH phase II study, a clinical trial evaluating the role of trastuzumab deruxtecan in patients with HER2-positive or HER2 low-expressing metastatic breast cancer with brain metastases and/or leptomeningeal carcinomatosis. She also collaborates in other clinical trials.  

Dr. Vaz Batista has been published in national and international medical journals and is actively involved in undergraduate and postgraduate teaching at NOVA Medical School, Algarve University, Portugal, and online platforms.

She has been a member of ESMO since 2015 and joined the ESMO Educational Publications Working Group in January 2022.

Last update: February 2022

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.